[
THE INVESTOR] As of Aug. 7 10:25 A.M., ViroMed increased 1.32%, compared with yesterday, to 107,600 won. It had increased 0.37% through the past month. Standard deviation, the volatility index for stock price, was 2.1% on the same period of time over one month.
Compared with its close competitors within the same industry, KOSDAQ, the monthly earnings rate of ViroMed was proper, while its volatility within 1 month was relatively lower than that of its peer group's. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was 0.1. Though its volatility was low, the return-on-risk on the whole was at the median. In spite of that, the return-on-risk is much better than the industrial mean, -3.1, and thus the industrial comparison performance was positive.
By HeRo (
hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.